Search Results 531-540 of 862 for NDC

1. Study of an Experimental Antisense Oligonucleotide Treatment for a Patient With LMNB1 Mutation Associated Autosomal Dominant Leukodystrophy (ADLD) - Mayo Clinic

   Currently there is no standard therapy for LMNB1 mutation associated Autosomal Dominant Leukodystrophy (ADLD), a fatal central nervous system white matter ...

2. Single-Ascending Dose Study of JK07 in Subjects With HFpEF - Mayo Clinic

   The purpose of this study is to assess the safety and tolerability profile of JK07, administered intravenously, according to protocol-defined dosing regimen.

3. Publications - Andrew C. Storm, M.D. - Mayo Clinic

   AbiMansour JP, Aggarwal M, Abou Zeid H, Rajan E, Storm AC. Transmural Gallbladder Drainage Using a Novel Endosonographic-Guided Suture Device.

4. Pancreatic Cancer Clinical Trials - Mayo Clinic Research

   Cystic tumors of the pancreas are fluid-filled growths. They are often treated by surgical removal. A safe and effective non-surgical treatment is desirable.

5. A Study to Evaluate At Home Administration of Pertuzumab Combined with Trastuzumab to Treat Patients with HER2-Positive Breast Cancer During COVID-19 Pandemic - Mayo Clinic

   The purpose of this study is to assess the safety of PH FDC SC when administered at home by an HHNP. Patients will be assessed for safety by regular evaluation ...

6. Mayo GBM PDX Line Data - Translational Neuro-Oncology: Jann N. Sarkaria - Mayo Clinic Research

   Mayo Clinic Brain Tumor Patient-Derived Xenograft National Resource: Growth characteristics, invasiveness, subtypes, tissue microarray & clinical data.

7. A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis - Mayo Clinic

   Systemic Sclerosis (SSc) is a devastating disease of unknown etiology. Patients suffer from multiple organ fibrosis whereas lung fibrosis (interstitial lung ...

8. News Cycle

   Vitamin D supplementation may help shape how the immune system responds to gut bacteria in people with inflammatory bowel disease (IBD), according to a Mayo ...

9. Infectious Diseases Clinical Trials - Mayo Clinic Research

   Laboratory testing from this study will be paired along with clinically significant data including medical history, bacterial infection types, inflammatory ...

10. Study of Datopotamab Deruxtecan (Dato-DXd) in Combination With Durvalumab and Carboplatin for First-Line Treatment of Patients With Advanced NSCLC Without Actionable Genomic Alterations - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...